Use of BIOFIRE® Pneumonia Panel Plus on sputum from patients with Cystic fibrosis or PCD

P. Koliopoulos (Mainz, Germany), J. Jurak (Mainz, Germany), S. Schlotter (Mainz, Germany), O. Nitsche (Mainz, Germany), K. Bohn (Mainz, Germany), D. Schreiner (Mainz, Germany), S. Gehring (Mainz, Germany), K. Poplawska (Mainz, Germany)

Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Session: Microbiology and antimicrobial strategies in cystic fibrosis
Session type: E-poster session
Number: 694
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Koliopoulos (Mainz, Germany), J. Jurak (Mainz, Germany), S. Schlotter (Mainz, Germany), O. Nitsche (Mainz, Germany), K. Bohn (Mainz, Germany), D. Schreiner (Mainz, Germany), S. Gehring (Mainz, Germany), K. Poplawska (Mainz, Germany). Use of BIOFIRE® Pneumonia Panel Plus on sputum from patients with Cystic fibrosis or PCD. 694

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Sputum processing methods in airway disease: Which is best?
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014

Novel protein biomarkers of bronchiectasis in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Value of bronchoalveloar lavage (BAL) in management of lung infections in adult cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015


Retrospective analysis of treatment with Ivacaftor/Lumacaftor in patients with cystic fibrosis at the Munich Cystic Fibrosis Centers
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018



Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018




Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Detection of helicobacter pylori by PCR in idiopathic pulmonary fibrosis (IPF) lung biopsies
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014


Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016

Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Adaptation of prevotella during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016


Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia
Source: International Congress 2014 – ILDs 4
Year: 2014

Inflammatory biomarkers in urine of cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014


Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014